首页> 美国卫生研究院文献>Diabetes Care >Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

【2h】

Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

机译：根据患者治疗的肾功能微血管和心血管成果每周治疗一次exenatide：Excel审判的见解

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

To evaluate the impact of once-weekly exenatide (EQW) on microvascular and cardiovascular (CV) outcomes by baseline renal function in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).

机译：通过基线肾功能在心血管事件降低（Excel）的杂湿研究中，评估一次每周exenatide（EQW）对微血管和心血管（CV）结果的影响。

著录项

期刊名称 Diabetes Care
作者
M. Angelyn Bethel; Robert J. Mentz; Peter Merrill; John B. Buse; Juliana C. Chan; Shaun G. Goodman; Nayyar Iqbal; Neli Jakuboniene; Brian Katona; Yuliya Lokhnygina; Renato D. Lopes; Aldo P. Maggioni; Peter Ohman; Tsvetalina Tankova; George L. Bakris; Adrian F. Hernandez; Rury R. Holman;
展开▼
作者单位

展开▼
年(卷),期 2020(43),2
年度 2020
页码 446–452
总页数 7
原文格式 PDF
正文语种
中图分类护理学;
关键词

相似文献

外文文献
中文文献
专利

1. 每周一次的紫杉烷–蒽环类联合方案与3周一次的以蒽环类为基础方案治疗r局部晚期乳腺癌的随机对照研究 [J] . Qiu-Wen Tan, Ting Luo, Hong Zheng, 癌症（英文版） . 2018,第002期
2. Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial [J] . Bethel M. Angelyn, Mentz Robert J., Merrill Peter, Diabetes care . 2020,第2期

机译：根据患者治疗的肾功能微血管和心血管成果，每周治疗一次exenatide：Excel审判的见解
3. Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights From the EXSCEL Trial [J] . Mentz Robert J., Bethel M. Angelyn, Thompson Vivian P., Circulation: An Official Journal of the American Heart Association . 2017,第24期

机译：exenatide每周对2型糖尿病和心血管疾病患者临床结果的影响：Excel审判的见解
4. Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes Insights From the EXSCEL Trial [J] . Fudim Marat, White Jennifer, Pagidipati Neha J., Circulation: An Official Journal of the American Heart Association . 2019,第20期

机译：2型糖尿病患者曾经每周艾肽的影响，没有心力衰竭和心力衰竭和心力衰竭的结果洞察力从Excel试验中有所了解
5. Impact of Renal Insufficiency on 30-Day Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention [C] . Sakai K., Tosaka A., Soga Y., World Congress on Heart Disease. . 2013

机译：肾功能不全对初级经皮冠状动脉干预治疗的ST段升高心肌梗死患者30天后的影响
6. Is there an increased risk of cardiovascular disease in patients with functional adrenal incidentalomas vs. nonfunctional adrenal incidentalomas. [D] . Khan, Tooba Fatima. 2015

机译：功能性肾上腺偶发瘤与非功能性肾上腺偶发瘤患者心血管疾病的风险增加了吗？
7. Effects of exenatide and open-label SGLT2 inhibitor treatment given in parallel or sequentially on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial [O] . Lindsay E. Clegg, Robert C. Penland, Srinivas Bachina, 2019

机译：艾塞那肽和开放标签的SGLT2抑制剂治疗并行或依次给予对2型糖尿病的死亡率以及心血管和肾脏结局的影响：EXSCEL试验的见解
8. 5257Effects of once-weekly exenatide on clinical outcomes in the subgroup of patients with pre-existing cardiovascular disease: insights from EXSCEL [O] . R J Mentz, V P Thompson, S M Gustavson, 2018

机译：每周寄生在患有预先存在的心血管疾病患者患者亚群的临床结果中的5257次数：excel的见解

Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

摘要

著录项

相似文献

相关主题

期刊订阅